PNPLA3 and portal hypertension: However, despite the evidence supporting the impact of PNPLA3 rs738409 G-allele carriage on liver disease progression, changes in surrogates of portal hypertension were comparable between carriers and non-carriers of the PNPLA3 rs738409 G-allele, indicating the absence of an impact on liver disease regression.